Cytokine response modifier A (CrmA) inhibits ceramide formation in response to tumor necrosis factor (TNF)-alpha: CrmA and Bcl-2 target distinct components in the apoptotic pathway.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples